SHP655 (rADAMTS13)

rADAMTS13 · Shire

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHP655 (rADAMTS13), covering 2024-04-23 to 2024-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHP655 (rADAMTS13) in Sickle Cell Disease [Phase 1]